** Shares of Thermo Fisher TMO.N are down 1.5% to $428.26 on Mon after HSBC analysts cut their PT
** TMO is on track to lose ground after two consecutive sessions of gains
** HSBC cut TMO PT to $540 from $560
** Among 31 analysts that cover TMO, avg rating is "BUY" and median PT is $550, down from $560 a month ago
** TMO is down ~18% YTD vs S&P 500 health index .SPXHC, which is down ~2%
(Reporting by Chibuike Oguh in New York)
((Email: Chibuike.Oguh@thomsonreuters.com; Phone: +332-219-1834; Reuters Messaging: chibuike.oguh.thomsonreuters.com@reuters.net))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.